Lack of effect of influenza immunisation on anticoagulant control in patients on long-term warfarin

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 7, 2007, Pages 786-789

  MacCallum, Peter ^a,b   Madhani, Manisha ^a   Mt Isa, Shahrul ^b   Ashby, Deborah ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Anticoagulation; Influenza vaccine; Warfarin

Indexed keywords

INFLUENZA VACCINE; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLEEDING DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DRUG POTENTIATION; DRUG SAFETY; FEMALE; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INJECTION SITE REACTION; INTERNATIONAL NORMALIZED RATIO; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SKIN BRUISING; THROMBOSIS;

AGED; ANTICOAGULANTS; BLOOD COAGULATION; DRUG INTERACTIONS; FEMALE; HEMORRHAGE; HUMANS; INFLUENZA VACCINES; INTERNATIONAL NORMALIZED RATIO; MALE; OUTPATIENT CLINICS, HOSPITAL; PROSPECTIVE STUDIES; THROMBOSIS; WARFARIN;

EID: 34547525294     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1347     Document Type: Article

References (11)

1. Gardiner C, Williams K, Mackie IJ, Machin SJ, Cohen H. Patient self-testing is a reliable and acceptable alternative to laboratory monitoring. Br J Haematol 2005; 128: 242-247.
2. Farrow PR, Nicholson KG. Lack of effect of influenza and pneumococcal vaccines on anticoagulation by warfarin. J Infect 1984; 9: 157-160.
3. Lipsky BA, Pecoraro RE, Roben NJ, de Blaquire P, Delaney CJ. Influenza vaccination and warfarin anticoagulation. Ann Intern Med 1984; 100: 835-837.
4. Souto JC, Oliver A, Montserrat I, Mateo J, Sureda A, Fontcuberta J. Lack of effect of influenza vaccine on anticoagulation by acenocoumarol. Ann Pharmacother 1993; 27: 365-368.
5. Raj G, Kumar R, McKinney WP. Safety of intramuscular influenza immunization among patients receiving long-term warfarin anticoagulant therapy. Arch Intern Med 1995; 155: 1529-1531.
6. Palache AM. Influenza vaccines. A reappraisal of their use. Drugs 1997; 54: 841-856.
7. Poli D, Chiarugi L, Capanni M, et al. Need of more frequent international normalized ratio monitoring in elderly patients on long-term anticoagulant therapy after influenza vaccination. Blood Coagul Fibrinolysis 2002; 13: 297-300.
8. Paliani U, Filippucci E, Gresele P. Significant potentiation of anticoagulation by flu-vaccine during the season 2001-2002. Haematologica 2003; 88: 599-600.
9. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126: 204S-233S.
10. The Department of Health. Immunisation against infectious disease. The Green Book 1996 (updated November 2005). Accessed at www.dh.gov.uk/ assetRoot/04/12/33/47/04123347.pdf on 24 April 2006.
11. Cook IF, Barr I, Hartel G, Pond D, Hampson AW. Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults. Vaccine 2006; 24: 2395-2402.